《联邦食品、药品和化妆品法案》项下的直接与附带CBD责任
人们很少关注大麻二酚(CBD)的附带责任问题。为什么呢?很可能是因为美国食品药品监督管理局(FDA)在涉及CBD时,从未对任何协助或教唆违反《食品、药品和化妆品法案》(该法案)的公司或个人采取过任何严肃的执法行动。尽管如此,根据CBD的附带责任规定——
人们很少关注大麻二酚(CBD)的附带责任问题。为什么呢?很可能是因为美国食品药品监督管理局(FDA)在涉及CBD时,从未对任何协助或教唆违反《食品、药品和化妆品法案》(该法案)的公司或个人采取过任何严肃的执法行动。尽管如此,根据CBD的附带责任规定——
The federal Gun Control Act of 1968 deems cannabis users “prohibited persons” who cannot legally own or possess firearms. In the past, numerous petitioners failed to overturn convictions under this law. That is now changing. In a recent case known as United States v. Harrison, a federal court ruled that cannabis use alone does not
It’s no secret that state cannabis markets across the nation are suffering badly. Because of I.R.C. 280E, lack of access to financial institutions, massive operational expenses, plunging prices, and just gluts of production, it’s not pretty out there. However, there’s a newish light at the end of the tunnel, at least for California and other
自2018年《农业法案》通过以来,大麻CBD行业一直热切期待FDA出台CBD监管规定。在此期间,FDA召集工作组研究如何监管含CBD的食品和膳食补充剂。截至2023年1月26日,FDA最终决定将不监管含CBD的食品或
马丁·路德·金纪念日快乐!是时候稍微危言耸听一下了。去年此时,我以这样的话开篇:若马丁·路德·金今日仍在世,他几乎肯定会倡导终结禁毒战争。金博士生前从未公开谈论毒品或大麻问题——他遇刺身亡于
2023年大麻销售商能否迎来税制改革?具体而言,国会是否终于会采取行动,解决《美国法典》第26编第280E条("IRC 28oE")给行业带来的困扰?虽然希望渺茫,但一切皆有可能。在多次尝试推动《安全银行法案》通过未果后——
美国食品药品监督管理局(FDA)围绕大麻二酚(CBD)监管的讨论层出不穷,令人眼花缭乱。多年来,人们始终在猜测FDA何时——甚至是否——会提出并采纳CBD监管条例。迄今为止,尽管该机构就该议题征集公众意见,但FDA主要...
在美国注册商标必须满足合法商业使用的要求。对于大麻品牌而言,这意味着美国专利商标局(USPTO)不会为涉及联邦法律禁止产品的商标提供注册,其中最显著的当属大麻。然而,USPTO在合法商业使用方面的处理方式存在争议——
Cosmetics are something of a bright spot when it comes to federal cannabis regulation. Unfortunately, however, there is quite a bit of misunderstanding when it comes to the federal legal framework for cannabis cosmetics. Following up on question that was asked during a recent webinar, here are the basics of which cannabis brands should be
As we blogged about last week, the SAFE Banking Act is trying to claw its way back from the dead during this lame duck session of Congress. Interestingly, on December 2, Punchbowl News reported that the Department of Justice (DOJ) issued a memo outlining its “issues” with the SAFE Banking Act. Here’s the memo (“Memo”).